Fractional CO₂ Laser or 40% Urea With Topical Fluconazole Microemulsion in Onychomycosis
ConditionOnychomycosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAssiut University
About this trial
To evaluate the efficacy and safety of topical fluconazole microemulsion enhanced by fractional CO₂ laser versus by 40% urea ablation in treatment of Onychomycosis.
Eligibility criteria
Qualifiers
Clinically and mycologically confirmed onychomycosis
No topical antifungal use in the past 1 month
No systemic antifungal use in the past 3 months
Disqualifiers
pregnancy or lactation
Nail disorders such as psoriasis, eczema, lichen planus
patients have a known allergy to any of the study treatments
Trial design
Treatments tested in this trial
- "Fractional CO2 laser" and "topical fluconazole microemulsion"
- "Urea 40%" and "topical fluconazole microemulsion"
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov